Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Invivyd, Inc. | IVVD | $0.64 | $188.44M | — | |
| PepGen Inc. | PEPG | $2.72 | $188.14M | — | |
| Yarrow Bioscience Inc | YARW | $20.17 | $187.67M | — | — |
| Evommune, Inc. | EVMN | $5.17 | $187.63M | — | |
| Compugen Ltd. | CGEN | $2.12 | $187.55M | 5.2 | — |
| Whitehawk Therapeutics, Inc. | WHWK | $3.29 | $187.27M | — | |
| Alpha Cognition Inc. Common Stock | ACOG | $8.58 | $186.85M | — | |
| Precision BioSciences, Inc. | DTIL | $6.71 | $185.21M | — | |
| Eledon Pharmaceuticals, Inc. | ELDN | $2.26 | $183.65M | — | |
| Entrada Therapeutics, Inc. | TRDA | $4.65 | $181.06M | — | |
| Sutro Biopharma, Inc. | STRO | $10.79 | $178.91M | — | |
| Innate Pharma S.A. | IPHA | $1.57 | $175.37M | — | |
| Sionna Therapeutics, Inc. | SION | $3.87 | $174.73M | — | |
| Oramed Pharmaceuticals Inc. | ORMP | $4.14 | $172.21M | 1.0 | 6.02% |
| Coherus Oncology, Inc. | CHRS | $1.02 | $165.32M | — | |
| Adagene Inc. | ADAG | $2.41 | $161.82M | — | |
| NervGen Pharma Corp. | NGEN | $1.50 | $161.28M | — | |
| ALX Oncology Holdings Inc. | ALXO | $1.15 | $159.02M | — | |
| NovaBridge Biosciences | NBP | $1.37 | $158.92M | — | |
| Compass Therapeutics, Inc. | CMPX | $0.81 | $158.30M | — | |
| MediWound Ltd. | MDWD | $12.10 | $156.21M | — | |
| Upstream Bio, Inc. | UPB | $2.80 | $153.36M | — | |
| Veraxa Biotech AG | VRXA | $1.06 | $149.89M | — | |
| Protara Therapeutics, Inc. | TARA | $2.50 | $147.74M | — | |
| Acumen Pharmaceuticals, Inc. | ABOS | $2.03 | $146.80M | — | |
| Codexis, Inc. | CDXS | $1.29 | $144.55M | — | |
| Jyong Biotech Ltd. | MENS | $1.89 | $143.69M | — | |
| Molecular Partners AG | MOLN | $3.72 | $142.50M | — | |
| Canton Strategic Holdings, Inc. | CNTN | $1.93 | $137.85M | — | |
| Cue Biopharma, Inc. Common Stock | CUE | $18.95 | $137.66M | — | |
| Atrium Therapeutics, Inc. | RNA | $8.00 | $136.85M | — | |
| Korro Bio, Inc. | KRRO | $9.29 | $136.80M | — | |
| Outlook Therapeutics, Inc. | OTLK | $0.56 | $136.65M | — | |
| AN2 Therapeutics, Inc. | ANTX | $3.60 | $135.85M | — | |
| TuHURA Biosciences, Inc. | HURA | $2.09 | $132.87M | — | |
| Tiziana Life Sciences Ltd | TLSA | $1.01 | $128.53M | — | |
| Anavex Life Sciences Corp. | AVXL | $1.36 | $126.07M | — | |
| Nkarta, Inc. | NKTX | $1.75 | $125.34M | — | |
| Retension Pharmaceuticals, Inc. | RTSN | $15.00 | $124.97M | — | |
| Voyager Therapeutics, Inc. | VYGR | $2.02 | $124.47M | — | |
| Spruce Biosciences, Inc. | SPRB | $42.73 | $122.81M | — | |
| Foghorn Therapeutics Inc. | FHTX | $2.04 | $121.15M | — | |
| Black Diamond Therapeutics, Inc. | BDTX | $2.08 | $118.61M | — | |
| Humacyte, Inc. | HUMA | $0.41 | $114.23M | — | |
| Minerva Neurosciences, Inc. | NERV | $2.39 | $114.12M | — | |
| NRx Pharmaceuticals, Inc. | NRXP | $2.63 | $113.87M | — | |
| Armata Pharmaceuticals, Inc. | ARMP | $3.06 | $113.78M | — | |
| Seer, Inc. | SEER | $2.03 | $112.41M | — | |
| Cellectis S.A. | CLLS | $0.97 | $110.81M | — | |
| vTv Therapeutics Inc. | VTVT | $27.77 | $109.80M | — |
Invivyd, Inc.
Healthcare / Biotechnology
- Market Cap
- $188.44M
- P/E
- unprofitable
PepGen Inc.
Healthcare / Biotechnology
- Market Cap
- $188.14M
- P/E
- unprofitable
Yarrow Bioscience Inc
Healthcare / Biotechnology
- Market Cap
- $187.67M
Evommune, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.63M
- P/E
- unprofitable
Compugen Ltd.
Healthcare / Biotechnology
- Market Cap
- $187.55M
- P/E
- 5.2
Whitehawk Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.27M
- P/E
- unprofitable
Alpha Cognition Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $186.85M
- P/E
- unprofitable
Precision BioSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $185.21M
- P/E
- unprofitable
Eledon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $183.65M
- P/E
- unprofitable
Entrada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $181.06M
- P/E
- unprofitable
Sutro Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $178.91M
- P/E
- unprofitable
Innate Pharma S.A.
Healthcare / Biotechnology
- Market Cap
- $175.37M
- P/E
- unprofitable
Sionna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $174.73M
- P/E
- unprofitable
Oramed Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $172.21M
- P/E
- 1.0
- Dividend Yield
- 6.02%
Coherus Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $165.32M
- P/E
- unprofitable
Adagene Inc.
Healthcare / Biotechnology
- Market Cap
- $161.82M
- P/E
- unprofitable
NervGen Pharma Corp.
Healthcare / Biotechnology
- Market Cap
- $161.28M
- P/E
- unprofitable
ALX Oncology Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $159.02M
- P/E
- unprofitable
NovaBridge Biosciences
Healthcare / Biotechnology
- Market Cap
- $158.92M
- P/E
- unprofitable
Compass Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $158.30M
- P/E
- unprofitable
MediWound Ltd.
Healthcare / Biotechnology
- Market Cap
- $156.21M
- P/E
- unprofitable
Upstream Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $153.36M
- P/E
- unprofitable
Veraxa Biotech AG
Healthcare / Biotechnology
- Market Cap
- $149.89M
- P/E
- unprofitable
Protara Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $147.74M
- P/E
- unprofitable
Acumen Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $146.80M
- P/E
- unprofitable
Codexis, Inc.
Healthcare / Biotechnology
- Market Cap
- $144.55M
- P/E
- unprofitable
Jyong Biotech Ltd.
Healthcare / Biotechnology
- Market Cap
- $143.69M
- P/E
- unprofitable
Molecular Partners AG
Healthcare / Biotechnology
- Market Cap
- $142.50M
- P/E
- unprofitable
Canton Strategic Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $137.85M
- P/E
- unprofitable
Cue Biopharma, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $137.66M
- P/E
- unprofitable
Atrium Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.85M
- P/E
- unprofitable
Korro Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.80M
- P/E
- unprofitable
Outlook Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.65M
- P/E
- unprofitable
AN2 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $135.85M
- P/E
- unprofitable
TuHURA Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $132.87M
- P/E
- unprofitable
Tiziana Life Sciences Ltd
Healthcare / Biotechnology
- Market Cap
- $128.53M
- P/E
- unprofitable
Anavex Life Sciences Corp.
Healthcare / Biotechnology
- Market Cap
- $126.07M
- P/E
- unprofitable
Nkarta, Inc.
Healthcare / Biotechnology
- Market Cap
- $125.34M
- P/E
- unprofitable
Retension Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $124.97M
- P/E
- unprofitable
Voyager Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $124.47M
- P/E
- unprofitable
Spruce Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $122.81M
- P/E
- unprofitable
Foghorn Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $121.15M
- P/E
- unprofitable
Black Diamond Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $118.61M
- P/E
- unprofitable
Humacyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $114.23M
- P/E
- unprofitable
Minerva Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $114.12M
- P/E
- unprofitable
NRx Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $113.87M
- P/E
- unprofitable
Armata Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $113.78M
- P/E
- unprofitable
Seer, Inc.
Healthcare / Biotechnology
- Market Cap
- $112.41M
- P/E
- unprofitable
Cellectis S.A.
Healthcare / Biotechnology
- Market Cap
- $110.81M
- P/E
- unprofitable
vTv Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $109.80M
- P/E
- unprofitable
Showing 301–350 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.